Giovanni D. Aletti

Predicting residual disease and extent of surgery after neoadjuvant chemotherapy for ovarian cancer: Does the MSKCC model from the primary setting apply?

Journal: Gynecologic oncology

Published: June 19, 2026

Secondary cytoreduction for ovarian cancer relapse: results from the high surgical quality, multi-center "Surgery in Recurrent Ovarian Cancer Research Consortium (SURROC-CON)".

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: June 07, 2026

Impact of indocyanine green fluorescence angiography on anastomotic leak in ovarian cancer cytoreductive surgery: a retrospective cohort study.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: May 27, 2026

Gliomatosis peritonei and ectopic decidua in pregnancy after treatment for immature teratoma.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: April 03, 2026

Defining surgical fitness in advanced ovarian cancer: a critical review of predictors, algorithms, and pre-habilitation.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: February 23, 2026

Rate and risk factors of venous thromboembolism during neoadjuvant chemotherapy for advanced ovarian cancer: a retrospective analysis from a referral center.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: January 09, 2026

Single-port robotic surgery in gynecologic oncology: feasibility and safety after 1 year of implementation.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: November 22, 2025

Lymphadenectomy in early-stage ovarian cancer: is there still a role?

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: November 10, 2025

Lymphadenectomy in early-stage ovarian cancer: is there still a role?

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: November 10, 2025

Management of Patients with Epithelial Ovarian Cancer: A Systematic Comparison of International Guidelines from Scientific Societies (AIOM-BGCS-ESGO-ESMO-JGSO-NCCN-NICE).

Journal: Cancers

Published: November 02, 2025

Predicting residual disease and extent of surgery after neoadjuvant chemotherapy for ovarian cancer: Does the MSKCC model from the primary setting apply?

Predicting residual disease and extent of surgery after neoadjuvant chemotherapy for ovarian cancer: Does the MSKCC model from the primary setting apply?

Secondary cytoreduction for ovarian cancer relapse: results from the high surgical quality, multi-center "Surgery in Recurrent Ovarian Cancer Research Consortium (SURROC-CON)".

Secondary cytoreduction for ovarian cancer relapse: results from the high surgical quality, multi-center "Surgery in Recurrent Ovarian Cancer Research Consortium (SURROC-CON)".

Impact of indocyanine green fluorescence angiography on anastomotic leak in ovarian cancer cytoreductive surgery: a retrospective cohort study.

Impact of indocyanine green fluorescence angiography on anastomotic leak in ovarian cancer cytoreductive surgery: a retrospective cohort study.

Gliomatosis peritonei and ectopic decidua in pregnancy after treatment for immature teratoma.

Gliomatosis peritonei and ectopic decidua in pregnancy after treatment for immature teratoma.

Defining surgical fitness in advanced ovarian cancer: a critical review of predictors, algorithms, and pre-habilitation.

Defining surgical fitness in advanced ovarian cancer: a critical review of predictors, algorithms, and pre-habilitation.

Rate and risk factors of venous thromboembolism during neoadjuvant chemotherapy for advanced ovarian cancer: a retrospective analysis from a referral center.

Rate and risk factors of venous thromboembolism during neoadjuvant chemotherapy for advanced ovarian cancer: a retrospective analysis from a referral center.

Single-port robotic surgery in gynecologic oncology: feasibility and safety after 1 year of implementation.

Single-port robotic surgery in gynecologic oncology: feasibility and safety after 1 year of implementation.

Lymphadenectomy in early-stage ovarian cancer: is there still a role?

Lymphadenectomy in early-stage ovarian cancer: is there still a role?

Lymphadenectomy in early-stage ovarian cancer: is there still a role?

Lymphadenectomy in early-stage ovarian cancer: is there still a role?

Management of Patients with Epithelial Ovarian Cancer: A Systematic Comparison of International Guidelines from Scientific Societies (AIOM-BGCS-ESGO-ESMO-JGSO-NCCN-NICE).

Management of Patients with Epithelial Ovarian Cancer: A Systematic Comparison of International Guidelines from Scientific Societies (AIOM-BGCS-ESGO-ESMO-JGSO-NCCN-NICE).

Single-port robotic splenectomy in secondary cytoreduction for recurrent high-grade serous ovarian cancer.

Single-port robotic splenectomy in secondary cytoreduction for recurrent high-grade serous ovarian cancer.

Detection rate of sentinel lymph nodes in early-stage endometrial cancer according to age.

Detection rate of sentinel lymph nodes in early-stage endometrial cancer according to age.